These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 2799341

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. High and intermediate resolution DNA typing systems for class I HLA-A, B, C genes by hybridization with sequence-specific oligonucleotide probes (SSOP).
    Cao K, Chopek M, Fernández-Viña MA.
    Rev Immunogenet; 1999; 1(2):177-208. PubMed ID: 11253946
    [Abstract] [Full Text] [Related]

  • 5. Selection of unrelated bone marrow donors: does the current procedure warrant complete MHC class II identity?
    Eiermann TH, Ballas M, Fakler J, Müller C, Wölpl A, Goldmann SF.
    Beitr Infusionsther; 1992; 30():320-3. PubMed ID: 1284725
    [Abstract] [Full Text] [Related]

  • 6. Analysis of HLA-D micropolymorphism by a simple procedure: RNA oligonucleotide hybridization.
    Ucla C, van Rood JJ, Gorski J, Mach B.
    J Clin Invest; 1987 Oct; 80(4):1155-9. PubMed ID: 2443537
    [Abstract] [Full Text] [Related]

  • 7. The incidence of DPB1 differences between serological and mixed lymphocyte culture matched unrelated individuals: implications for selection of bone marrow donors.
    Eiermann TH, Fakler J, Goldmann SF.
    Bone Marrow Transplant; 1992 Mar; 9(3):157-60. PubMed ID: 1387332
    [Abstract] [Full Text] [Related]

  • 8. A new approach for the analysis of HLA class II polymorphism: 'HLA oligotyping'.
    Tiercy JM, Jeannet M, Mach B.
    Blood Rev; 1990 Mar; 4(1):9-15. PubMed ID: 2108745
    [Abstract] [Full Text] [Related]

  • 9. Molecular HLA-class II typing: advantages and clinical application.
    Loiseau P, al-Daccak R, David F, Colombani J.
    Nouv Rev Fr Hematol (1978); 1991 Mar; 33(6):461-3. PubMed ID: 1687830
    [Abstract] [Full Text] [Related]

  • 10. DNA typing of primate major histocompatibility complex (Mhc)-DQA1 locus by PCR and dot blot hybridization.
    Mwenda JM, Shotake T, Yamamoto T, Uchihi R, Bambra CS, Katsumata Y.
    Cell Mol Biol (Noisy-le-grand); 1999 Dec; 45(8):1249-56. PubMed ID: 10643974
    [Abstract] [Full Text] [Related]

  • 11. Influence of HLA-DP mismatches on primary MLR responses in unrelated HLA-A, B, DR, DQ, Dw identical pairs in allogeneic bone marrow transplantation.
    Cesbron A, Moreau P, Milpied N, Muller JY, Harousseau JL, Bignon JD.
    Bone Marrow Transplant; 1990 Nov; 6(5):337-40. PubMed ID: 1981326
    [Abstract] [Full Text] [Related]

  • 12. DRB polymerase chain reaction fingerprinting, DQA oligotyping and mixed lymphocyte culture results in related bone marrow donors and recipients.
    Brojer E, Sankowska M, Stańczak JJ, Gronkowska A, Stepień-Sopniewska B, Górski A, Zupańska B.
    Arch Immunol Ther Exp (Warsz); 1995 Nov; 43(2):89-92. PubMed ID: 8744721
    [Abstract] [Full Text] [Related]

  • 13. [Gene amplification with PCR and sequence specific HLA oligonucleotide typing].
    Holzberger G, Frank R, Boehm BO, Seidl S.
    Beitr Infusionsther; 1992 Nov; 30():341-3. PubMed ID: 1284730
    [Abstract] [Full Text] [Related]

  • 14. Molecular techniques for typing unrelated marrow donors: potential impact of molecular typing disparity on donor selection.
    Baxter-Lowe LA.
    Bone Marrow Transplant; 1994 Nov; 14 Suppl 4():S42-50. PubMed ID: 7728125
    [Abstract] [Full Text] [Related]

  • 15. The use of polymerase chain reaction (PCR) gene amplification and synthetic oligonucleotide probes for HLA-DP typing in bone marrow transplantation.
    Howell WM, Evans PR, Sage DA, Lambert CM, Wilson PJ, Smith JL.
    Bone Marrow Transplant; 1990 Jan; 5(1):66-7. PubMed ID: 2297593
    [No Abstract] [Full Text] [Related]

  • 16. Identification of unrelated HLA-identical bone marrow donors: RFLP, oligotyping and PCR fingerprinting for HLA class II compared to MLC responses.
    Mazzola G, el-Borai MH, Berrino M, Cornaglia M, Amoroso A.
    Bone Marrow Transplant; 1993 Jan; 11 Suppl 1():24-7. PubMed ID: 8095414
    [Abstract] [Full Text] [Related]

  • 17. Strategies and technical challenges in allele level Class II typing in 2578 bone marrow transplantation donor-recipient pairs.
    Williams TM, Winden T, Setterholm M, Vierra-Green CA, Spellman S, Flesch S, Awdeh Z, Baxter-Lowe LA, Begovich AB, Fernandez-Vina M, Hegland J, Hurley CK, Johnson D, Noreen H, Salazar M, Schmeckpeper B, Yunis EJ.
    Hum Immunol; 2008 Jan; 69(4-5):227-34. PubMed ID: 18486756
    [Abstract] [Full Text] [Related]

  • 18. HLA class II typing by restriction fragment length polymorphism (RFLP) in unrelated bone marrow transplant patients.
    Noreen HJ, Davidson ML, McCullough J, Bach FH, Segall M.
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2968-70. PubMed ID: 2468247
    [No Abstract] [Full Text] [Related]

  • 19. A comparison of serological, cellular and DNA-RFLP methods for HLA matching in the selection of related bone marrow donors.
    Howell WM, Evans PR, Spellerberg MB, Wilson PJ, Smith JL.
    Bone Marrow Transplant; 1989 Jan; 4(1):63-8. PubMed ID: 2522330
    [Abstract] [Full Text] [Related]

  • 20. Molecular analysis of HLA genes for the selection of unrelated bone marrow donor.
    Mantovani V, Martinelli G, Bragliani M, Buzzi M, Selva P, Collina E, Farabegoli P, Rosti GA, Bandini G, Tura S.
    Bone Marrow Transplant; 1995 Sep; 16(3):329-35. PubMed ID: 8535303
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.